Literature DB >> 2156162

Central nervous system side effects of ganciclovir.

C L Davis, S Springmeyer, B J Gmerek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2156162     DOI： 10.1056/NEJM199003293221315

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  [Use-risk consideration of anti-infective agents from the point of view of the licensing authority].

Authors:  W Christ; B Esch
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 2.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 3.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  Foscarnet penetrates the blood-brain barrier: rationale for therapy of cytomegalovirus encephalitis.

Authors:  U R Hengge; N H Brockmeyer; R Malessa; U Ravens; M Goos
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

Review 5.  Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.

Authors:  Nancy Perrottet; Laurent A Decosterd; Pascal Meylan; Manuel Pascual; Jerome Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

6.  Pharmacokinetics of ganciclovir in a patient undergoing chronic haemodialysis.

Authors:  F Combarnous; D Fouque; N Bernard; R Boulieu; P Chossegros; M Laville; P Zech
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

7.  A case of severe ganciclovir-induced encephalopathy.

Authors:  Hikaru Sakamoto; Makito Hirano; Kazuhiro Nose; Shuichi Ueno; Takashi Oki; Koichi Sugimoto; Tsukasa Nishioka; Susumu Kusunoki; Yusaku Nakamura
Journal:  Case Rep Neurol       Date:  2013-10-05

8.  Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients.

Authors:  Eliška Dvořáčková; Martin Šíma; Jakub Petrus; Eva Klapková; Petr Hubáček; Jiří Pozniak; Jan Havlín; Robert Lischke; Ondřej Slanař
Journal:  Pharmaceutics       Date:  2022-02-13       Impact factor: 6.321

9.  Antimicrobial-induced cognitive side effects.

Authors:  Amanda Warstler; Jennifer Bean
Journal:  Ment Health Clin       Date:  2016-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.